cyclopentane has been researched along with Pulmonary Disease, Chronic Obstructive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, R; Li, R; Li, X; Qian, F; Song, Y; Sun, L; Wu, Y; Yang, X; Ye, RD | 1 |
| D'Amico, A; Di Natale, C; Galluccio, G; Martinelli, E; Paolesse, R; Pennazza, G; Roscioni, C; Santonico, M | 1 |
2 other study(ies) available for cyclopentane and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
MLN4924 protects against interleukin-17A-induced pulmonary inflammation by disrupting ACT1-mediated signaling.
Topics: Adaptor Proteins, Signal Transducing; Animals; Cell Line; Chemokine CXCL1; Cyclopentanes; Disease Models, Animal; Enzyme Inhibitors; Humans; Hypertension, Pulmonary; Interleukin-17; Interleukin-1beta; Interleukin-6; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Pneumonia; Pulmonary Disease, Chronic Obstructive; Pyrimidines; TNF Receptor-Associated Factor 6; Ubiquitination | 2019 |
An investigation on electronic nose diagnosis of lung cancer.
Topics: Adenocarcinoma; Aged; Aniline Compounds; Biomarkers, Tumor; Breath Tests; Complex Mixtures; Cyclopentanes; Diagnosis, Differential; Feasibility Studies; Gas Chromatography-Mass Spectrometry; Humans; Lung Neoplasms; Middle Aged; Predictive Value of Tests; Pulmonary Disease, Chronic Obstructive; Sensitivity and Specificity; Toluidines | 2010 |